Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice

Drug Alcohol Depend. 2018 Oct 1:191:14-24. doi: 10.1016/j.drugalcdep.2018.05.029. Epub 2018 Jul 7.

Abstract

Background: A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD). Although behavioral therapy has some success in treating CUD, many users relapse, often citing altered sleep, mood, and irritability. Preclinical animal tests of cannabinoid withdrawal focus primarily on somatic-related behaviors precipitated by a cannabinoid receptor antagonist. The goal of the present study was to develop novel cannabinoid withdrawal assays that are either antagonist-precipitated or spontaneously induced by abstinence.

Methods: C57BL/6 J mice were repeatedly administered the phytocannabinoid Δ9-tetrahydrocannabinol (THC; 1, 10 or 50 mg/kg, s.c.), the synthetic cannabinoid receptor agonist JWH-018 (1 mg/kg, s.c.), or vehicle (1:1:18 parts ethanol:Kolliphor EL:saline, s.c.) for 6 days. Withdrawal was precipitated with the cannabinoid receptor inverse agonist rimonabant (3 mg/kg, i.p.) or elicited via abstinence (i.e., spontaneous withdrawal), and putative stress-related behavior was scored. Classic somatic signs of cannabinoid withdrawal were also quantified.

Results: Precipitated THC withdrawal significantly increased plasma corticosterone. Precipitated withdrawal from either THC or JWH-018 suppressed marble burying, increased struggling in the tail suspension test, and elicited somatic withdrawal behaviors. The monoacylglycerol lipase inhibitor JZL184 attenuated somatic precipitated withdrawal but had no effect on marble burying or struggling. Spontaneous THC or JWH-018 withdrawal-induced paw tremors, head twitches, and struggled in the tail suspension test after 24-48 h abstinence. JZL184 or THC attenuated these spontaneous withdrawal-induced behaviors.

Conclusion: Outcomes from tail suspension and marble burying tests reveal that THC withdrawal is multifaceted, eliciting and suppressing behaviors in these tests, in addition to inducing well-documented somatic signs of withdrawal.

Keywords: Cannabinoid withdrawal; Cannabis use disorder; Drug dependence; Marijuana; Stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Benzodioxoles / adverse effects
  • Cannabinoid Receptor Agonists / adverse effects*
  • Dronabinol / adverse effects
  • Indoles / adverse effects
  • Male
  • Marijuana Abuse / etiology*
  • Mice
  • Mice, Inbred C57BL
  • Naphthalenes / adverse effects
  • Piperidines / adverse effects
  • Pyrazoles / adverse effects
  • Rimonabant
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Benzodioxoles
  • Cannabinoid Receptor Agonists
  • Indoles
  • JZL 184
  • Naphthalenes
  • Piperidines
  • Pyrazoles
  • Dronabinol
  • 1-pentyl-3-(1-naphthoyl)indole
  • Rimonabant